Cancer Research
Page 1 • 6 itemsGain critical insights into global cancer research trends, drug development pipelines, and clinical trial advancements for strategic pharma investment.
Biotheryx BTX-9341 Phase 1A Results to Be Presented at ESMO Breast Cancer Congress 2026
Biotheryx announces Phase 1A dose escalation study results for BTX-9341, a CDK4/6 degrader for HR+/HER2- breast cancer treatment at ESMO 2026.
Alpha Tau Treats First Patient with Alpha DaRT in European Pancreatic Cancer Trial ACAPELLA
Alpha Tau initiates Alpha DaRT treatment in ACAPELLA trial for locally advanced pancreatic cancer, addressing unmet need for 42,000 European patients annually.
Alpha Tau Treats First European Pancreatic Cancer Patient with Alpha DaRT in ACAPELLA Clinical Trial
Alpha Tau successfully treats first European patient with Alpha DaRT radiotherapy in French ACAPELLA trial for locally advanced pancreatic cancer.
RedHill's Opaganib Shows Promise in Neuroblastoma and Triple-Negative Breast Cancer Studies at AACR 2026
RedHill's opaganib demonstrates enhanced efficacy in neuroblastoma chemotherapy combinations and improved anti-tumor immunity in TNBC preclinical studies.
RedHill's Opaganib Shows Promise in Neuroblastoma and Triple-Negative Breast Cancer Studies at AACR 2026
RedHill's opaganib demonstrates enhanced efficacy in neuroblastoma chemotherapy combinations and improved anti-tumor immunity in preclinical cancer studies.
Boehringer Ingelheim and Zai Lab Launch Phase Ib/II Trial for DLL3-Targeting Combination Therapy in Small Cell Lung Cancer
Boehringer Ingelheim partners with Zai Lab to test obrixtamig plus zocilurtatug pelitecan combination in Phase Ib/II trial for SCLC and neuroendocrine carcinomas.